Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate ...

Cornell silica nanoparticles eliminated prostate tumors in mice by triggering ferroptosis and activating immune response, ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers. The discovery, published Dec. 13 in ...

Researchers have developed a fully human antibody that suppressed tumor growth and metastatic spread in preclinical models of ...

Immunotherapies, anti-cancer treatments that enhance the immune system's ability to kill cancer cells, have made notable ...

Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

If a prostate cancer cell were a car, the androgen receptor (AR) would be part of its ignition system, enabling cancer cells to respond to hormonal signals that drive growth. For decades, therapies ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...